| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 07/02/2008 | EP1937248A2 Alcanoic acid amides substituted by saturated o-heterocycles |
| 07/02/2008 | EP1937242A2 Methods and compositions for the treatment of neuropsychiatric and addictive disorders |
| 07/02/2008 | EP1937237A1 Novel phloroglucinol derivatives having selectin ligand activity |
| 07/02/2008 | EP1742930B1 Pyrethroid pesticide |
| 07/02/2008 | EP1692127B1 Triphenylethylene compounds as selective estrogen receptor modulators |
| 07/02/2008 | EP1633702B1 Protease inhibitors |
| 07/02/2008 | EP1593666B1 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 07/02/2008 | EP1296940B1 Amidine derivatives as selective antagonists of nmda receptors |
| 07/02/2008 | CN101213173A Process for production of optically active aminopentane derivative, intermediate and process for producing the intermediate |
| 07/02/2008 | CN101210003A Method for preparing ligustilide |
| 07/02/2008 | CN101210002A Method for separating and preparing salvianolic acid B chemical reference substance |
| 07/02/2008 | CN101210001A Production of tetrahydrofuran from 1,4-butanediol |
| 07/02/2008 | CN100398529C Method for the production of maleic anhydride |
| 07/02/2008 | CN100398516C Synthesis of taxol enhancers |
| 07/01/2008 | US7393963 Conversion of 2,5-(hydroxymethyl)furaldehyde to industrial derivatives, purification of the derivatives, and industrial uses therefor |
| 07/01/2008 | US7393961 Nonexplosive intermediates for preparation of fluoropolymers; environmentally friendly; including stable, high yield hypofluorite reactive molecules |
| 07/01/2008 | US7393873 Arylsulfonamide derivatives |
| 07/01/2008 | US7393846 phosphodiesterase type 4 inhibitors; N-(3,5-dichloropyrid-4-yl)-4-difluoromethoxy-8-methanesulfonamido-dibenzo[b,d]furan-1-carboxamide; antiinflammatory agent, antiallergen; asthma or chronic obstructive pulmonary disease |
| 06/26/2008 | WO2008076427A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof |
| 06/26/2008 | WO2008075353A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | WO2008074132A1 Inhibitors of histone deacetylase and prodrugs thereof |
| 06/26/2008 | WO2008055970A3 Methods for the preparation of hexahydrofuro[2,3-b]furan-3-ol |
| 06/26/2008 | WO2008053437A3 A method for preparing ascorbic acid or a salt thereof from plant matrices |
| 06/26/2008 | US20080154049 for acylation of an aromatic compound, comprising reacting an aromatic compound and an acylating agent of the carboxylic acid type, in the presence of a Lewis acid and of a silylated reagent selected from the group consisting of halosilanes and halosiloxanes. |
| 06/26/2008 | US20080154048 Use of a Multi-Layer Catalyst for Producing Phthalic Anhydride |
| 06/26/2008 | US20080153991 Method of making carbon nanotube patterned film or carbon nanotube composite using carbon nanotubes surface-modified with polymerizable moieties |
| 06/26/2008 | US20080153873 Dihydrobenzofuranyl derivatives and methods of their use |
| 06/26/2008 | US20080153836 1H-Quinazoline-2,4-Diones |
| 06/26/2008 | US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder |
| 06/26/2008 | US20080152950 Anthracene derivative and organic electroluminescent device using the same |
| 06/26/2008 | DE102006061913A1 New amide compounds used for treatment of gynecological diseases e.g. endometriosis, for female fertility control and female hormone replacement therapy, has general formula |
| 06/26/2008 | CA2695613A1 Sulfonamide derivatives with therapeutic indications |
| 06/26/2008 | CA2672192A1 Inhibitors of histone deacetylase and prodrugs thereof |
| 06/25/2008 | EP1935887A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligands |
| 06/25/2008 | EP1935882A1 Bicyclic compounds |
| 06/25/2008 | EP1935879A1 Substituted cycloalkene derivative |
| 06/25/2008 | EP1935874A1 S1p3 receptor antagonist |
| 06/25/2008 | EP1935869A1 Retinoids for the treatment of emphysema |
| 06/25/2008 | EP1934299A1 Lactone marker comprising double bond ester group and method for marking and detecting the same |
| 06/25/2008 | EP1934194A1 Anti-malarial compound isolated from gomphostema niveum |
| 06/25/2008 | EP1853614A4 Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans |
| 06/25/2008 | EP1730140B1 Opioid receptor antagonists |
| 06/25/2008 | EP0986382B1 Raf kinase inhibitors |
| 06/25/2008 | CN101208324A Benzo[b]furane and benzo[b]thiophene derivatives |
| 06/25/2008 | CN101208297A Antiviral compounds and methods |
| 06/25/2008 | CN101205222A Total synthesis of Rocaglamide and uses thereof as insecticidal agent |
| 06/25/2008 | CN100396783C Extracting process of chinese starjasmine stem lignin aglycone total extract and its products |
| 06/25/2008 | CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 06/25/2008 | CN100396668C Non-imidazole aryloxypiperidines |
| 06/25/2008 | CN100396667C Unsaturated five heterocycle compound for up-regulating bone formation protein BMP-2 expression activity |
| 06/24/2008 | US7390913 Process for the preparation of racemic citalopram diol and/or S- or R-citalopram diols and the use of such diols for the preparation of racemic citalopram, R-citalopram and/or S-citalopram |
| 06/24/2008 | US7390911 Method for producing phthalic anhydride |
| 06/24/2008 | US7390908 Such as 2-[3,5-Di(2-chlorobenzyloxy)benzoyl)amino]-thiazole; for treatment of diabetes |
| 06/24/2008 | US7390833 osteoarthritis; compounds inhibit Aggrecanase Activity of a disintegrin and metalloprotease with thrombosondin type I motifs; biaryl sulfonamid derivatives; N-({4'-[2-4-methylisoquinolin-3-yl)ethyl]-1,1 '-biphenyl-4-yl}sulfonyl)-D-valine |
| 06/24/2008 | US7390803 N-(3,5-bis-trifluoromethyl-benzyl)-1-(2-tert-butoxycarbonyl-amino-thiazol-4-yl)-3-(N-methyl, N-tetrahydro-4H-pyran-4-ylamino]-cyclopentanecarbamide; monocyte chemoattractant protein (MCP) receptor antagonist; antiinflammatory agent; antiallergen; autoimmune diseases; rhinitis, dermatitis, asthma |
| 06/19/2008 | WO2008073943A1 Dihydrobenzofuranyl derivatives and methods of their use |
| 06/19/2008 | WO2008073461A2 Ion channel modulators |
| 06/19/2008 | WO2008072652A1 Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and alignment film |
| 06/19/2008 | WO2008071696A1 Improved process for preparing substituted carboxylic anhydrides |
| 06/19/2008 | WO2008071455A1 Bicyclic acyltryptophanols |
| 06/19/2008 | WO2008071359A1 Substituted aminofuranones and their use |
| 06/19/2008 | WO2007069020A3 N-hydroxyamide derivatives possessing antibacterial activity |
| 06/19/2008 | US20080146810 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 06/19/2008 | US20080146659 Administering Taxiresinol, (7'R)-7'-Hydroxylariciresinol, Secoisolariciresinol and Isotaxiresinol, which are lignans contained in Hongdoushan contained in Hongdoushan, as the active ingredients for reducing the blood glucose level |
| 06/19/2008 | US20080146624 Amidines as modulators of indoleamine 2,3-dioxygenase |
| 06/19/2008 | US20080146579 Treatment of patients with chronic pulmonary diseases and nutritional compositions therefore |
| 06/19/2008 | US20080145901 Novel process for the preparation of 3,5-di-o-acyl-2-fluoro-2-c-methyl-d-ribono-gamma-lactone |
| 06/19/2008 | DE102006059319A1 Substituierte Aminofuranone und ihre Verwendung Substituted aminofuranones and their use |
| 06/19/2008 | CA2823243A1 Methods of processing biomass comprising electron-beam radiation |
| 06/19/2008 | CA2672503A1 Substituted aminofuranones and their use |
| 06/19/2008 | CA2672464A1 Dihydrobenzofuranyl derivatives and methods of their use |
| 06/18/2008 | EP1863783A4 Improved process for preparing insecticidal (disubstitutedpropenyl) phenylalkyl substituted dihydrobenzofurans |
| 06/18/2008 | EP0885210B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use |
| 06/18/2008 | CN101203614A Chemoenzymatic process for the synthesis of escitalopram |
| 06/18/2008 | CN101203501A Dihydrobenzofuranyl alkanamine derivatives as 5HT2C agonists |
| 06/18/2008 | CN101203490A Reactive monomer and resin composition containing same |
| 06/18/2008 | CN101203218A Benzofuranyl alkanamine derivatives and uses as 5-HT2C excitant thereof |
| 06/18/2008 | CN101200472A Method for preparing 3-amido-4-imino rifamycin S |
| 06/18/2008 | CN101200465A Decahydronaphthalene compounds and medical uses thereof |
| 06/18/2008 | CN100395241C Degradeable furan sesterterpenes keratinous spongistatin, and its preparing method and use |
| 06/17/2008 | US7388118 Amine 1,2- and 1,3-diol compounds |
| 06/17/2008 | US7388101 Tetrahydrofuran derivatives having cis substituent, their intermediates, and their preparation method |
| 06/17/2008 | US7388006 Non-steroidal progesting |
| 06/17/2008 | US7387805 soybean saponin and/or malonyl isoflavone glycoside; a food or drink, a medicine, a cosmetic, an oral preparation, a dentifrice, an aromatic agent, a deodorant, detergent |
| 06/17/2008 | US7387800 Mixture containing plant extract; renin, angiogenesis inhibitor; cardiovascular disorders; antidiabetic agents; liver disorders; gall stones; gastrointestinal disorders |
| 06/12/2008 | WO2008070606A1 Hydrofluoroethξr compounds and processes for their preparation and use |
| 06/12/2008 | WO2008069374A1 Quorum sensing antagonist, method of preventing a biofilm formation using the quorum sensing antagonist and method of reducing a bacterial contamination using the quorum sensing antagonist |
| 06/12/2008 | WO2008068974A1 Aurone derivative-containing composition for diagnosis |
| 06/12/2008 | WO2008067997A1 Preparation of 4-hydroxy-2,5-dimethyl-2,3-dihydrofuran-3-one |
| 06/12/2008 | WO2008067911A1 Biphenyl-substituted spirocyclic ketoenols |
| 06/12/2008 | WO2007148208A3 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands |
| 06/12/2008 | WO2007135104A8 Production of phthalic anhydride by gas phase oxidation of o-xylol |
| 06/12/2008 | WO2007089548A3 Compounds and methods for modulating protein trafficking |
| 06/12/2008 | US20080140037 Crosslinker for Superabsorbent Polymers |
| 06/12/2008 | US20080139827 Method for improving the shelf-life of hematoxylin staining solutions |
| 06/12/2008 | US20080139825 Process For Producing Optically Active Beta-Hydroxy-Alpha-Aminocarboxylic Acid Derivative |
| 06/12/2008 | US20080139802 Converting 2'-deoxy-2'-fluoro-2'-methyl-D-ribonolactones derivatives to 3-fluoro-3-methyl-2-chlorofuran compounds using chlorinating agent such as sulfuryl chloride, thionyl chloride or phosphorus oxychloride and tetrabutylammonium bromide |
| 06/12/2008 | US20080139622 Decahydronaphthalene Compounds |
| 06/12/2008 | US20080139599 e.g. 4-[6-(5-methyl-2-phenyloxazol-4-ylmethoxy)-1-oxoindan-5-yl]benzoic acid; antidiabetic and antilipemic agent, obesity; atherosclerosis; coupling benzene derivatives folowed by hydration and alkylation |
| 06/12/2008 | US20080139547 N-Hydroxyalkynylbenzamide (or hydroxamate) derivatives; anticarcinogenic and antiproliferative agents |